Cite
HARVARD Citation
Jani, M. et al. (2015). Clinical Utility of Random Anti–Tumor Necrosis Factor Drug–Level Testing and Measurement of Antidrug Antibodies on the Long‐Term Treatment Response in Rheumatoid Arthritis. Arthritis & rheumatology. 67 (8), pp. 2011-2019. [Online].